These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25980295)

  • 41. Extended-release niacin raises adiponectin and leptin.
    Westphal S; Borucki K; Taneva E; Makarova R; Luley C
    Atherosclerosis; 2007 Aug; 193(2):361-5. PubMed ID: 16887123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 'desaturase hypothesis' for atherosclerosis: Janus-faced enzymes in omega-6 and omega-3 polyunsaturated fatty acid metabolism.
    Martinelli N; Consoli L; Olivieri O
    J Nutrigenet Nutrigenomics; 2009; 2(3):129-39. PubMed ID: 19776640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjunctive lipid lowering therapy in the era of surrogate endpoints.
    Silverman MG; Blaha MJ; Blumenthal RS
    Cardiol Rev; 2011; 19(1):17-22. PubMed ID: 21135598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2013 Aug; 110(2):366-77. PubMed ID: 23740299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
    Han SH; Sakuma I; Shin EK; Koh KK
    Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocyte-suppressing effect of bezafibrate but not omega-3 fatty acids in patients with isolated hypertriglyceridaemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):23-9. PubMed ID: 21223512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent clinical studies of the effects of lipid-modifying therapies.
    Gotto AM; Moon JE
    Am J Cardiol; 2012 Jul; 110(1 Suppl):15A-26A. PubMed ID: 22697388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits.
    Fournier N; Tuloup-Minguez V; Pourci ML; Thérond P; Jullian JC; Wien F; Leroy M; Dallongeville J; Paul JL; Leroy A
    Biochimie; 2013 Jun; 95(6):1278-87. PubMed ID: 23410672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats.
    Aissaoui A; Zizi S; Israili ZH; Lyoussi B
    J Ethnopharmacol; 2011 Sep; 137(1):652-61. PubMed ID: 21718774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A key role for dietary bioactives in the prevention of atherosclerosis.
    de Roos B
    Mol Nutr Food Res; 2012 Jul; 56(7):1001-2. PubMed ID: 22760976
    [No Abstract]   [Full Text] [Related]  

  • 52. Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk.
    Aguilo G; Vinuela I; Verd S
    JAMA Cardiol; 2021 Dec; 6(12):1466-1467. PubMed ID: 34613352
    [No Abstract]   [Full Text] [Related]  

  • 53. Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk-Reply.
    Armstrong MK; Fraser BJ; Magnussen CG
    JAMA Cardiol; 2021 Dec; 6(12):1467-1468. PubMed ID: 34613327
    [No Abstract]   [Full Text] [Related]  

  • 54. Is there an optimal diet for primordial prevention of atherosclerosis?
    Maki KC; Dicklin MR
    Eur Heart J; 2022 Sep; 43(34):3189-3191. PubMed ID: 35938853
    [No Abstract]   [Full Text] [Related]  

  • 55. Report on the Physiological Action of the Active Principles of Urechites Suberecta.
    Stockman R
    Br Med J; 1892 Jun; 1(1642):1295-300. PubMed ID: 20753753
    [No Abstract]   [Full Text] [Related]  

  • 56. [The basis principles of primary prevention of atherosclerosis].
    Titov VN
    Klin Med (Mosk); 2014; 92(12):19-29. PubMed ID: 25980295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypoglycemic activity of hypolipidemic preparations].
    Titov VN
    Klin Med (Mosk); 2014; 92(5):18-28. PubMed ID: 25782302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lipolysis in very low density lipoproteins - locus minoris resistentiae - in the pathogenesis of hypertriglyceridemia. Positive effects of diet, polyenic fatty acids, statins and fibrates.].
    Titov VN; Rozhkova TA; Amelyshkina VA; Kukharchuk VV; Kotlovsky MY; Yakimenko AV; Kurdoyak EV
    Klin Lab Diagn; 2019; 64(7):388-396. PubMed ID: 31408589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Formation in the phylogenesis of three pulls of cells with expressed different absorption and metabolism of fatty acids. Insulin and medium chains fatty acids.].
    Titov VN; Aripovskiy AV; Dmitriev LF; Medvedev OS
    Klin Lab Diagn; 2018; 63(12):732-740. PubMed ID: 30785686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The atherosclerosis and atheromatosis as two etiologically different aphysiological processes at single pathogenesis. Atheromatosis and pathogenetic role of insulin.].
    Rozhkova TA; Titov VN; Kaminnaya VI
    Klin Lab Diagn; 2017; 62(12):708-718. PubMed ID: 30856301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.